Tag Archives: Intellectual Property

Patent Reform Legislation Off The Table For Now

Williams

If the mainstream media is to be believed, the patent system is broken.  This notion is frequently blamed on the perceived increase in so-called patent assertion entities (“PAEs”), referred to derogatorily as “patent trolls.”  More often than not, these media reports cite to a limited number of examples illustrating the perceived abuses, and reach the conclusion that patents are stifling innovation.  And, even though there has been serious disagreement about the extent of the problem, Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Supreme Court Decision on Web Content Delivery to Impact Biotech Patents

Zuhn

Earlier this month, in Limelight Networks, Inc. v. Akamai Technologies, Inc., the Supreme Court issued a decision that will likely impact patents directed to methods for treating or diagnosing diseases.  In Limelight Networks, the Court reversed the appellate court’s finding that Limelight had infringed U.S. Patent No. 6,108,703, which is assigned to the Massachusetts Institute of Technology and is exclusively licensed to Akamai Technologies.  In particular, the Court determined that a defendant is not liable Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

IP at the 2014 BIO International Convention

San Diego

Securing and maintaining intellectual property protection for the next generation of biotech innovation faces new challenges and opportunities.  Come learn about current issues and those just on the horizon before they affect your practice and your company. Keynote Speakers in the IP Track: Director General Francis Gurry, World Intellectual Property Organization Judge Randall R. Rader, United States Court of Appeals for the Federal Circuit Acting Director Michelle Lee, United States Patent and Trademark Office IP Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Why We Need IPR for GMOs

GMO Answers

At GMO Answers, we’ve received several questions about corporate intellectual property rights (IPR) and patents on GMO seeds, with many believing that patents hurt farmers by forcing them to purchase new seeds each year instead of using the seeds they harvest. On the contrary, patents actually help farmers gain access to new technologies by facilitating innovation, by enabling seed developers to invest significant time and resources in creating new technologies that will provide farmers with Read More >

Farmer Gene  |  1 Comment  |  Email This Post
Tags: , , , , , ,

Nautilus v. Biosig, Baxter v. Fresenius and Limelight v. Akamai

Supreme Court

BIO weighed in on three Supreme Court cases in the last few months whose outcome could change the IP landscape for biotechnology companies. BIO’s amicus brief in Nautilus v. Biosig Instruments argues that the petitioner misrepresents the Federal Circuit’s definiteness test and seeks to litigate an issue not properly before this court.  Petitioner’s approach radically departs from established law and practice.  Finally the petitioner’s approach would destabilize the patent system as it would inject substantial Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,